These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33588862)

  • 21. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
    Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
    J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S; Bai H; Fei S; Miao B
    Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma.
    Dai J; Pan Y; Chen Y; Yao S
    Front Genet; 2022; 13():1024508. PubMed ID: 36406134
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma.
    Ma C; Zhang W; Wu Q; Liu Y; Wang C; Lao G; Yang L; Liu P
    PLoS One; 2018; 13(3):e0193625. PubMed ID: 29513728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma.
    Zhu J; Zhao R; Xu W; Ma J; Ning X; Ma R; Meng F
    Biosci Trends; 2020 Sep; 14(4):279-284. PubMed ID: 32536673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of
    Lin H; Wang J; Shi Q; Wu M
    PeerJ; 2024; 12():e17338. PubMed ID: 38708353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
    Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
    Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma.
    Liu L; Yin P; Yang R; Zhang G; Wu C; Zheng Y; Wu S; Liu M
    Front Immunol; 2024; 15():1351908. PubMed ID: 38863714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
    Zhu Q; Tian G; Gao J
    Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of
    Zhao S; Yu M
    DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
    Lin W; Feng M; Chen G; Zhou Z; Li J; Ye Y
    Oncol Rep; 2017 Mar; 37(3):1477-1486. PubMed ID: 28098890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations.
    Li N; Yu K; Lin Z; Zeng D
    Exp Biol Med (Maywood); 2022 Feb; 247(3):207-220. PubMed ID: 34674573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Prognostic Features Based on Neutrophil-Related Genes for Lung Squamous Cell Carcinoma Reveals Immune Landscape and Drug Candidates.
    Sili D; Nan Z
    Rev Invest Clin; 2024; 76(2):116-131. PubMed ID: 38740381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and Validation of a Protein Prognostic Model for Lung Squamous Cell Carcinoma.
    Fang X; Liu X; Weng C; Wu Y; Li B; Mao H; Guan M; Lu L; Liu G
    Int J Med Sci; 2020; 17(17):2718-2727. PubMed ID: 33162799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.